Adults 21 to 89, any sex, with Caregiver Burnout. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
The Number of Caregivers Who Complete the ChecklistPrimary· Through study completion, up to 1 year
The number of caregivers who complete the checklist
Group
Value
95% CI
Caregiver Checklist (CHEC)
28
Acceptable Length of CHEC, as Measured by the Number of Caregivers Who Report That the Checklist is an Acceptable LengthPrimary· Post intervention, at 1 week
Acceptable length of CHEC, as measured by the number of caregivers who report that the checklist is an acceptable length
Group
Value
95% CI
Caregiver Checklist (CHEC)
23
CHEC's Ease of Use, as Measured by the Number of Caregivers Who Report That the Checklist is Easy to UsePrimary· Post intervention, at 1 week
CHEC's ease of use, as measured by the number of caregivers who report that the checklist is easy to use
Group
Value
95% CI
Caregiver Checklist (CHEC)
25
CHEC's Helpfulness in Identify Caregivers' Needs, as Measured by the Number of Caregivers Who Report That the Checklist is Helpful in Identifying Their NeedsPrimary· Post intervention, at 1 week
CHEC's helpfulness in identify caregivers' needs, as measured by the number of caregivers who report that the checklist is helpful in identifying their needs
Group
Value
95% CI
Caregiver Checklist (CHEC)
20
CHEC's Helpfulness in Starting a Conversation With Health Care Providers About Caregivers' Needs, as Measured by the Number of Caregivers Who Report That the Checklist is Helpful in Starting a Conversation With Providers About Their NeedsPrimary· Post intervention, at 1 week
CHEC's helpfulness in starting a conversation with health care providers about caregivers' needs, as measured by the number of caregivers who report that the checklist is helpful in starting a conversation with providers about their needs
Group
Value
95% CI
Caregiver Checklist (CHEC)
22
Desire to Continue Use, as Measured by the Number Caregivers Who Report That They Desire to Continue Using the Checklist in the FuturePrimary· Post intervention, at 1 week
Desire to continue use, as measured by the number caregivers who report that they desire to continue using the checklist in the future
Group
Value
95% CI
Caregiver Checklist (CHEC)
15
Discussion of Caregivers' Needs, as Measured by the Number of Completed Checklists That Result in a Conversation With Providers About Caregiver Needs/ConcernsPrimary· Post intervention, at 1 week
Discussion of caregivers' needs, as measured by the number of completed checklists that result in a conversation with providers about caregiver needs/concerns
Group
Value
95% CI
Caregiver Checklist (CHEC)
22
Adverse events — posted to ClinicalTrials.gov
Time frame: 6 months.
Reporting threshold: 0%.
Adverse-event reports describe events observed during the trial — not all are caused by the drug.
The goal of this project is to pilot test CHEC (Collaborative Healthcare Encounters with Caregivers) in primary care. CHEC is brief intervention with two components: 1) a checklist to identify the needs and concerns of unpaid/family caregivers who accompany older patients (aged 65+) to their primary care visits and 2) accompanying Tip Sheet for clinicians.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
NCT06418971 — Testing & Refinement of CarePair: An Assessment and Referral Platform to Support Family Caregivers of Alzheimer's Diseas
· NA
· recruiting
NCT07167641 — Caring for the Carer
· NA
· recruiting
NCT07528261 — ACT Group for Stroke Caregivers
· NA
· recruiting
NCT06722352 — Palliative Care Education in Assisted Living for Dementia Care Providers (PCEAL-DCP)
· NA
· recruiting
NCT06687486 — Effect of Autogenic Relaxation Therapy on Caregivers on Perceived Stress Quality of Life and Caregiver Burden
· NA
· active not recruiting
Other Weill Medical College of Cornell University trials
Trials by the same sponsor.
NCT07485712 — Center for Research and Education on Aging and Technology Enhancement - CREATE V - Project 2
· NA
· not yet recruiting
NCT05811338 — Center for Research and Education on Aging and Technology Enhancement - CREATE V - Project 1
· NA
· not yet recruiting
NCT06118983 — Improving TRansitions ANd OutcomeS for Heart FailurE Patients in Home Health CaRe (I-TRANSFER-HF)
· NA
· recruiting
NCT06818734 — Implementation of a Clinical Decision Support Tool for Postpartum Depression
· NA
· not yet recruiting
NCT07485725 — Center for Research and Education on Aging and Technology Enhancement - CREATE V - Project 3
· NA
· not yet recruiting
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Weill Medical College of Cornell University
Last refreshed: 3 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04946942.